When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LGND - CStone antibody successful in late-stage lung cancer study
Ligand Pharmaceuticals Incorporated
A Phase 3 clinical trial evaluating CStone Pharmaceuticals' (OTCPK:CSPHF) PD-L1 inhibitor CS1001 for the first-line treatment of metastatic squamous and nonsquamous non-small cell lung cancer (NSCLC) met the primary endpoint of progression-free survival (PFS).
More news on: CSTONE PHARMACEUTICALS, Ligand Pharmaceuticals Incorporated, Healthcare stocks news,